Product NDC: | 57664-056 |
Proprietary Name: | Amlodipine Besylate |
Non Proprietary Name: | AMLODIPINE BESYLATE |
Active Ingredient(s): | 5 mg/1 & nbsp; AMLODIPINE BESYLATE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 57664-056 |
Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078552 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121019 |
Package NDC: | 57664-056-13 |
Package Description: | 500 TABLET in 1 BOTTLE (57664-056-13) |
NDC Code | 57664-056-13 |
Proprietary Name | Amlodipine Besylate |
Package Description | 500 TABLET in 1 BOTTLE (57664-056-13) |
Product NDC | 57664-056 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | AMLODIPINE BESYLATE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20121019 |
Marketing Category Name | ANDA |
Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
Substance Name | AMLODIPINE BESYLATE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |